Immunotherapeutic drugs such as TNF- and TLR-4, which have been reported in foreign studies, have been used on a small scale in the clinic, bringing new hope for the treatment of sepsis, but no successful efficacy has been achieved thus far [5]. The gene discussed is TNF; the disease is Sepsis.